Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
Yichang HEC Changjiang Pharma (1558 HK)
Watchlist
88
Analysis
Health Care
•
Hong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
China Traditional Chinese Medicine
•
15 Sep 2024 16:41
Merger Arb Mondays (16 Sep) - China TCM, Canvest, GA Pack, Raysum, Seven & I, Fuji Soft, Dyna-Mac
This week, the highest gross spreads are HEC Pharma (139.1%), Raysum (94.2%), Canvest (8.4%), GAPack (7.3%), China TCM (6.5%), Henlius (6.3%),...
Arun George
Follow
619 Views
Share
bullish
•
Haitong Securities Co Ltd (H)
•
09 Sep 2024 02:41
Guotai Junan (2611 HK) & Haitong (6837 HK) Merger Creates China's Major Player
A Guotai Junan (2611 HK)/Haitong (6837 HK) merger is welcome - possibly mandated - amid challenging capital markets and a tightening regulatory...
David Blennerhassett
Follow
587 Views
Share
bullish
•
Shinko Electric Industries
•
08 Sep 2024 16:39
Merger Arb Mondays (09 Sep) - Shinko, Fuji Soft, Pasco, GA Pack, CPMC, Latin Res, Capitol, PSC, Rex
This week, the highest gross spreads are HEC Pharma (116.0%), Canvest (8.4%), Shinko Electric (7.9%), Malaysia Airports (7.4%), GA Pack (6.9%),...
Arun George
Follow
433 Views
Share
bullish
•
Canvest Environmental Protection Group
•
01 Sep 2024 16:33
Merger Arb Mondays (02 Sep) - Canvest, China TCM, GA Pack, CPMC, Shinko, Arvida, SilverLake
This week, the highest gross spreads are HEC Pharma (109.7%), Canvest (13.7%), China TCM (8.5%), Malaysia Airports (7.8%), GA Pack (7.3%), Henlius...
Arun George
Follow
380 Views
Share
bullish
•
Shanghai Henlius Biotech
•
26 Aug 2024 01:29
Henlius (2696 HK): Was There Any Doubt?
The scrip option is here. Currently trading at a gross/annualised spread of 7.4%/16.2%, assuming mid-February payment. I'd get involved here. I'd...
David Blennerhassett
Follow
583 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.52.8
x